- Home
- CARA vs SLGL Comparison
CARA vs SLGL Comparison
Compare CARA & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARA
- SLGL
- Stock Information
- Founded
- CARA 2004
- SLGL 1997
- Country
- CARA United States
- SLGL Israel
- Employees
- CARA N/A
- SLGL N/A
- Industry
- CARA Biotechnology: Pharmaceutical Preparations
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- CARA Health Care
- SLGL Health Care
- Exchange
- CARA Nasdaq
- SLGL Nasdaq
- Market Cap
- CARA 16.7M
- SLGL 18.3M
- IPO Year
- CARA 2014
- SLGL 2018
- Fundamental
- Price
- CARA $0.25
- SLGL $0.48
- Analyst Decision
- CARA Hold
- SLGL Strong Buy
- Analyst Count
- CARA 3
- SLGL 2
- Target Price
- CARA $1.00
- SLGL $5.00
- AVG Volume (30 Days)
- CARA 1.6M
- SLGL 54.9K
- Earning Date
- CARA 11-14-2024
- SLGL 11-15-2024
- Dividend Yield
- CARA N/A
- SLGL N/A
- EPS Growth
- CARA N/A
- SLGL N/A
- EPS
- CARA N/A
- SLGL N/A
- Revenue
- CARA $8,686,000.00
- SLGL $11,707,000.00
- Revenue This Year
- CARA N/A
- SLGL $500.51
- Revenue Next Year
- CARA N/A
- SLGL N/A
- P/E Ratio
- CARA N/A
- SLGL N/A
- Revenue Growth
- CARA N/A
- SLGL 869.93
- 52 Week Low
- CARA $0.23
- SLGL $0.33
- 52 Week High
- CARA $1.15
- SLGL $1.58
- Technical
- Relative Strength Index (RSI)
- CARA 41.07
- SLGL 42.37
- Support Level
- CARA $0.24
- SLGL $0.44
- Resistance Level
- CARA $0.30
- SLGL $0.51
- Average True Range (ATR)
- CARA 0.02
- SLGL 0.04
- MACD
- CARA -0.00
- SLGL -0.00
- Stochastic Oscillator
- CARA 40.45
- SLGL 36.57
About CARA Cara Therapeutics Inc.
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.